for your info........
Deborah Ann Rathjen – Executive Chair, President & Chief Executive Officer
Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE, is the Chief Executive Officer and Executive Chair at Bioasis Technologies Inc. Prior to joining the Corporation, Dr. Rathjen was the Chief Executive Officer and Managing Director of Bionomics Limited, having joined Bionomics Limited, a public Australian biotechnology company engaged in the research and development of new therapies for brain disorders and cancer, in 2000 from Peptech Limited (now owned by Teva), where she was General Manager of Business Development and Licensing. She was a co-inventor of Peptech Limited’s TNF technology, which underpins the products Humira and Remicade used in the treatment of autoimmune disorders, and leader of the company’s successful defense of its key TNF patents against a legal challenge by BASF and Johnson and Johnson (J&J).
Dr. Rathjen has significant experience in company building and financing, mergers and acquisitions, therapeutic product research and development, business development, licensing and commercialization and has achieved in excess of $900 million in deals including 6 partnerships with Merck & Co., J&J, Abbott (AbbVie), Nycomed (Takeda), Chiesi Group and Merck KGaA. Dr. Rathjen has raised over $200 million in biotech company financings. Dr. Rathjen has been recognized internationally with awards and honors including the 2004 AusBiotech President’s Medal, 2006 Flinders University Distinguished Alumni Award, 2009 BioSingapore Asia Pacific Biotechnology Woman Entrepreneur of the Year, 2009 Regional Finalist Ernst & Young – Entrepreneur of the Year and 2014 Woman Executive of the Year BioPharm Industry Awards. In 2015 Dr. Rathjen was included in the top 50 most influential Australian businesswomen by The Australian newspaper.
Dr. Rathjen received her doctor of philosophy degree in immunology from Macquarie University in Sydney, Australia, and her bachelor of science degree, with honours, in immunology from Flinders University in Adelaide, Australia.